Osteopontin is elevated in Parkinson’s disease and its absence leads to reduced neurodegeneration in the MPTP model
Authors:
- Walter MaetzlerWMWalter Maetzler
- Daniela BergDBDaniela Berg
- Natalie SchalamberidzeNSNatalie Schalamberidze
- Arthur MelmsAMArthur Melms
- Klaus SchottKSKlaus Schott
- Jakob C. MuellerJMJakob C. Mueller
- Lucy LiawLLLucy Liaw
- Thomas GasserTGThomas Gasser
- Cordula NitschCNCordula Nitsch
- 1 March 2007
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 25 (3) , 473-482
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Molecular Pathways of Neurodegeneration in Parkinson's DiseaseScience, 2003
- Transient expression of osteopontin mRNA and protein in amoeboid microglia in developing rat brainExperimental Brain Research, 2003
- Parkinson's DiseaseNeuron, 2003
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003
- Mechanistic Approaches to Parkinson's Disease PathogenesisBrain Pathology, 2002
- Novel protein kinase C isoforms and mitogen-activated kinase kinase mediate phorbol ester-induced osteopontin expressionThe International Journal of Biochemistry & Cell Biology, 2002
- The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating DiseaseScience, 2001
- Flexible Structures of SIBLING Proteins, Bone Sialoprotein, and OsteopontinBiochemical and Biophysical Research Communications, 2001
- An assessment of the validity of densitometric measures of striatal tyrosine hydroxylase-positive fibers: relationship to apomorphine-induced rotations in 6-hydroxydopamine lesioned ratsJournal of Neuroscience Methods, 1990
- Astrocytes as a primary locus for the conversion MPTP into MPP+Journal of Neural Transmission, 1989